Public disclosures

Agah Ramtin

Company insiders · Executive Chairman and CMO · Director · RenovoRx, Inc.

Advertisement
FollowLatest SEC filingSEC filer historyProfile details as reported on 2026-11-17.Following & alerts
Reported transaction lines
1
Buy lines
1
Sell lines
0

Filing activity by month

Original filing lines in up to 12 months with activity.

  • 2026-111

Frequently disclosed stocks

Disclosure history

More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSource
Agah Ramtin

Executive Chairman and CMO · Director · RenovoRx, Inc.

RNXT

RenovoRx, Inc.

Buy
Filing details

SEC transaction code P

Common Stock · Direct ownership · Reported balance after transaction: 848460 · SEC code covers open-market or private transactions · Reflects open market purchases of the Issuer's securities. · Reflects a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $0.925 to $0.9299.

2026-11-162026-11-17

≈ $46,485.00

50,000 shares/units

SEC 4

Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.

Advertisement